Alangcas, Julita G.

HRN: 28-95-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
CEFTRIAXONE 1G (VIAL)
05/01/2026
05/07/2026
IV
2g
OD
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractUnspecified Sepsis    Compliance to guidelines: